Lilly could obtain approval for a weight loss pill that would unlock even more growth. Investors should never ignore valuations when picking stocks. The price a stock trades at can drastically ...

Approval for orforglipron would not only generate a lot of bullishness for the healthcare stock, but would also provide Eli Lilly with yet another blockbuster drug, and potentially enable it to ...

Lily Collins is celebrating all the love this Valentine's Day with her family. The " Emily in Paris " actress took to ...

Eli Lilly (NYSE: LLY) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in this morning's Q4 earnings report. Heading into the report, analysts ...

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Eli Lilly and Co. (LLY) and Shopify Inc. (SHOP), as well as a micro-cap stock ImmuCell Corp ...

If any pharmaceutical producer is going to exploit the full potential of such medications, it's the well-capitalized Eli Lilly. I would even consider it to be a leading healthcare stock ...

On Wednesday, Erste Group analysts upgraded Eli Lilly stock from Hold to Buy, citing a robust product demand and a promising pipeline of potential successes. The analysts highlighted the ...

Revenue from Zepbound leapt to $1.91 billion, up from $175.8 million a year earlier. Mounjaro's revenue rose to $3.53 billion. Lilly's stock climbed more than 2% Thursday morning.

Gene Munster, Deepwater Asset Management, joins 'Fast Money' to recap Tesla earnings. Mexico’s president explains 'in detail' why Google shouldn't rename Gulf of Mexico 14 Outdated Home Trends ...